Caption Management »

Monte Rosa Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 412k 24.20
2023-12-31 $2.4M 423k 5.65
2023-09-30 $1.7M 361k 4.79

More positions owned by Caption Management

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Western Digital (WDC)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Carvana Cl A Call Option (CVNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
United Therapeutics Corporation (UTHR)
Blue Owl Capital Com Cl A (OWL)
Tesla Motors (TSLA)
Take-Two Interactive Software (TTWO)
Cg Oncology (CGON)
Electronic Arts (EA)
Spdr Series Trust St Str Sp Regbnk (KRE)

View all positions for Caption Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
T. Rowe Price Associates
TCG Crossover Management
Vestal Point Capital
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Versant Venture Management
Braidwell
Geode Capital Management
American Century Companies
Marshall Wace

View all funds holding Monte Rosa Therapeutics